Details

---

Manufacturer
Remedica Ltd.(CYPRUS)
Registraction Number
MAL20016151AZ

Here’s the information about Imarem 400mg Film-Coated Tablets:

Content

Active Ingredient: Imatinib mesylate (400 mg per tablet), a protein-tyrosine kinase inhibitor.
Excipients: Includes stabilizing agents and inactive ingredients.

Indication

Used for the treatment of:
Chronic myeloid leukemia (CML) in various phases (blast crisis, accelerated phase, or chronic phase).
Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
Myelodysplastic/myeloproliferative diseases (MDS/MPD) associated with PDGFR gene rearrangements.
Hypereosinophilic syndrome (HES) and/or chronic eosinophilic leukemia (CEL).
Aggressive systemic mastocytosis (ASM).
Gastrointestinal stromal tumors (GIST).
Dermatofibrosarcoma protuberans (DFSP).

Instruction

Dosage:
Adults: The usual starting dose is 400–600 mg daily, depending on the condition being treated.
Pediatric patients: Dosage is based on body surface area and clinical guidelines.
Administration:
Take orally with water, preferably with a meal to minimize gastrointestinal discomfort.
Follow the prescribed schedule strictly.
Precautions:
Avoid use in patients with hypersensitivity to imatinib or its excipients.
Monitor for potential side effects such as nausea, fatigue, or edema.
Regular blood tests are recommended to monitor liver function and blood cell counts.